These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6757067)

  • 1. [Inhibitory effect of TN-762 (suprofen) on platelet aggregation].
    Imai H; Muramatsu Y; Niu K; Nozaki M; Fujimura H
    Nihon Yakurigaku Zasshi; 1982 Jul; 80(1):61-8. PubMed ID: 6757067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis. I. In vitro experiments.
    De Clerck F; Vermylen J; Reneman R
    Arch Int Pharmacodyn Ther; 1975 Aug; 216(2):263-79. PubMed ID: 1180617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of platelet anti-aggregation effect of several anti-inflammatory agents].
    Migne J; Santonja R; Kunz S
    Sem Hop; 1983 Dec; 59(46):3197-203. PubMed ID: 6318340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of alpha-(p-thenoylphenyl)-propionic acid (TN-762) on acute inflammatory reactions and prostaglandin biosynthesis].
    Fujimura H; Tsurumi K; Nakayama T; Kokuba S; Hiramatsu Y; Tamura Y
    Nihon Yakurigaku Zasshi; 1981 Mar; 77(3):321-36. PubMed ID: 7052360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-inflammatory, analgesic and antipyretic activities of alpha-(p-thenoylphenyl)-propionic acid (TN-762) (author's transl)].
    Fujimura H; Tsurumi K; Hasegawa J; Yanagihara M; Hiramatsu Y; Maekawa K
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):123-36. PubMed ID: 6979498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experiments.
    De Clerck F; Vermylen J; Reneman R
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):68-79. PubMed ID: 1190914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction of phenothiazinic anti-inflammatory agent, protizinic acid, with the biopolymers: Inhibitory effects on functions of platelets (author's transl)].
    Fujimura H; Tsurumi K; Nozaki M; Imai H; Niu K; Muramatsu Y
    Nihon Yakurigaku Zasshi; 1981 Jan; 77(1):27-39. PubMed ID: 7262705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of tetrahydroberberine on platelet aggregation and thrombosis.
    Xuan B; Wang W; Li DX
    Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):133-5. PubMed ID: 8010106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of 2-(4-(2-imidazo(1,2-a)pyridyl)phenyl) propionic acid (miroprofen) on platelet aggregation and prostaglandin I2 generation (author's transl)].
    Mikashima H; Goto K
    Yakugaku Zasshi; 1982 Jan; 102(1):99-103. PubMed ID: 7045328
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastrointestinal effects and acute toxicity of suprofen.
    Niemegeers CJ; Lenaerts FM; Awouters F; Janssen PA
    Arzneimittelforschung; 1975 Oct; 25(10):1537-42. PubMed ID: 1243036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of platelet agglutination and aggregation by aromatic amidino compounds.
    Geratz JD; Tidwell RR; Brinkhous KM; Mohammad SF; Dann O; Loewe H
    Thromb Haemost; 1978 Apr; 39(2):411-25. PubMed ID: 580990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
    Glass F; Lippton H; Kadowitz PJ
    Thromb Haemost; 1981 Dec; 46(4):676-9. PubMed ID: 6800048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human platelet function by parsalmide.
    Fantasia R; Colombi M; Della Volpe A; Pogliani EM
    Arzneimittelforschung; 1982; 32(10):1312-4. PubMed ID: 6897511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The inhibitory effect of oxaprozin, a new non-steroidal anti-inflammatory drug, on platelet aggregation].
    Goto J; Muramatsu M; Hosoda K; Otomo S; Aihara H
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):395-400. PubMed ID: 6432657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new platelet aggregation inhibitor which possesses hypolipemic and uricosuric properties, 2-[3-(2-thiazolylthio)phenyl]propionic acid (TPA).
    Minsker DH; Fanelli GM; Gilfillan JL; Huff JW; Jordan P; Kling P
    J Pharmacol Exp Ther; 1979 Jul; 210(1):37-42. PubMed ID: 448645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the inhibitory effect of etafenone hydrochloride on platelet aggregation].
    Ujiie A; Komatsu H; Kubota T; Hamano S; Naito J
    Nihon Yakurigaku Zasshi; 1983 Jun; 81(6):493-8. PubMed ID: 6618341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-platelet effects of isocarbacyclin methyl ester on human and rabbit platelets in vitro.
    Inoue K; Aoki Y; Kitahara S; Kiyoki M; Araki H
    Arzneimittelforschung; 1995 Sep; 45(9):975-9. PubMed ID: 7488316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane-mediated activation of platelets and enhancement of platelet uptake onto collagen-coated glass or deendothelialized rabbit aorta. Comparative effects of a thromboxane antagonist (EPO45) and a thromboxane synthetase inhibitor (dazoxiben).
    Menys VC; Davies JA
    Lab Invest; 1984 Feb; 50(2):184-9. PubMed ID: 6546403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of calcium antagonists on platelet function and vascular prostacyclin production.
    Pirich C; Schmid P; Fitscha P; Wytek R; O'Grady J; Sinzinger H
    Blood Press Suppl; 1994; 1():75-80. PubMed ID: 8205307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis.
    Srivastava R; Puri V; Srimal RC; Dhawan BN
    Arzneimittelforschung; 1986 Apr; 36(4):715-7. PubMed ID: 3521617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.